Keyphrases
Venous Thromboembolism
100%
Bleeding
100%
Multiple Myeloma
100%
MarketScan
100%
Bleeding Risk
100%
Anticoagulation
62%
Warfarin
25%
Diabetes
25%
Risk Factors
25%
Renal Disease
25%
Direct Oral Anticoagulants
25%
Antiplatelet Agents
25%
Serious Bleeding
25%
Low Molecular Weight Heparin
25%
High Risk
12%
Thromboprophylaxis
12%
Clinical Factors
12%
Charlson Comorbidity Index
12%
Cumulative Incidence
12%
Cancer-associated Venous Thromboembolism
12%
Cox Regression
12%
Venous Thromboembolic Events
12%
Bleeding Rate
12%
Comorbidity Index
12%
Commercial Databases
12%
Medicine and Dentistry
Multiple Myeloma
100%
Bleeding
100%
Venous Thromboembolism
100%
Anticoagulation
45%
Diabetes
18%
Nephropathy
18%
Warfarin
18%
Antiplatelet Drug
18%
Low Molecular Weight Heparin
18%
Direct Oral Anticoagulant
18%
Malignant Neoplasm
9%
Charlson Comorbidity Index
9%
Proportional Hazards Model
9%
Cumulative Incidence
9%
Thromboprophylaxis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
100%
Bleeding
100%
Multiple Myeloma
100%
Direct Oral Anticoagulant
18%
Comorbidity
18%
Kidney Disease
18%
Antithrombocytic Agent
18%
Warfarin
18%
Low Molecular Weight Heparin
18%
Malignant Neoplasm
9%